• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诺氟沙星的药代动力学及组织穿透性。

The pharmacokinetics and tissue penetration of norfloxacin.

作者信息

Adhami Z N, Wise R, Weston D, Crump B

出版信息

J Antimicrob Chemother. 1984 Jan;13(1):87-92. doi: 10.1093/jac/13.1.87.

DOI:10.1093/jac/13.1.87
PMID:6230344
Abstract

The pharmacokinetics and cantharides-induced blister fluid levels of norfloxacin were studied after a single 400 mg oral dose. The mean maximum serum level was 1.45 mg/l and occurred 1.5 h after administration. The serum half-life of norfloxacin was found to be 3.5 h. After 24 h 27% of the administered dose was recovered in the urine as microbiologically active compound. High urine levels were found. Rapid blister fluid penetration occurred, the maximum level (occurring between 2-3 h) was about 1 mg/l. Thereafter the blister fluid level exceeded the serum level, both declining in parallel.

摘要

单次口服400毫克诺氟沙星后,对其药代动力学及斑蝥素诱导水泡液中的诺氟沙星水平进行了研究。平均最大血清水平为1.45毫克/升,于给药后1.5小时出现。诺氟沙星的血清半衰期为3.5小时。24小时后,给药剂量的27%以具有微生物活性的化合物形式在尿液中回收。尿液中诺氟沙星水平较高。水泡液渗透迅速,最大水平(在2 - 3小时之间出现)约为1毫克/升。此后,水泡液水平超过血清水平,两者平行下降。

相似文献

1
The pharmacokinetics and tissue penetration of norfloxacin.诺氟沙星的药代动力学及组织穿透性。
J Antimicrob Chemother. 1984 Jan;13(1):87-92. doi: 10.1093/jac/13.1.87.
2
The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.依诺沙星和诺氟沙星的药代动力学及组织穿透性。
J Antimicrob Chemother. 1984 Sep;14 Suppl C:75-81. doi: 10.1093/jac/14.suppl_c.75.
3
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 (注:原文中多了一个of,正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin )
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
4
Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.新型三氟喹诺酮Ro 23-6240的药代动力学和组织穿透性
Antimicrob Agents Chemother. 1987 Feb;31(2):161-3. doi: 10.1128/AAC.31.2.161.
5
Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).曲伐沙星(CP-99,219)的药代动力学及在炎性液中的渗透情况
Antimicrob Agents Chemother. 1996 Jan;40(1):47-9. doi: 10.1128/AAC.40.1.47.
6
Norfloxacin disposition after sequentially increasing oral doses.依次增加口服剂量后诺氟沙星的处置情况。
Antimicrob Agents Chemother. 1983 Feb;23(2):284-8. doi: 10.1128/AAC.23.2.284.
7
Norfloxacin--a review of pharmacology and tissue penetration.诺氟沙星——药理学与组织穿透性综述
J Antimicrob Chemother. 1984 May;13 Suppl B:59-64. doi: 10.1093/jac/13.suppl_b.59.
8
Pharmacokinetics and tissue penetration of orally administered pefloxacin.口服培氟沙星的药代动力学及组织穿透性
Eur J Clin Microbiol. 1987 Oct;6(5):521-4. doi: 10.1007/BF02014239.
9
Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.诺氟沙星在健康志愿者以及肾、肝损伤患者中的药代动力学。
Eur J Clin Microbiol. 1983 Jun;2(3):253-9. doi: 10.1007/BF02029528.
10
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.AT-2266经口给予小鼠、大鼠、狗和猴后的药代动力学。
Antimicrob Agents Chemother. 1983 Jul;24(1):54-60. doi: 10.1128/AAC.24.1.54.

引用本文的文献

1
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.喹诺酮类药物:作用机制、致死性及其对抗生素耐药性的贡献。
Molecules. 2020 Dec 1;25(23):5662. doi: 10.3390/molecules25235662.
2
Antibiotic-containing polymers for localized, sustained drug delivery.用于局部、持续给药的含抗生素聚合物。
Adv Drug Deliv Rev. 2014 Nov 30;78:77-87. doi: 10.1016/j.addr.2014.04.006. Epub 2014 Apr 18.
3
Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials.氟喹诺酮类抗菌药物的定量结构与药代动力学的关系。
World J Gastroenterol. 2007 May 7;13(17):2496-503. doi: 10.3748/wjg.v13.i17.2496.
4
Absorption interactions with fluoroquinolones. 1995 update.氟喹诺酮类药物的吸收相互作用。1995年更新版。
Drug Saf. 1995 May;12(5):314-33. doi: 10.2165/00002018-199512050-00004.
5
Pharmacokinetics and tissue penetration of enoxacin.依诺沙星的药代动力学和组织穿透性。
Antimicrob Agents Chemother. 1984 Jul;26(1):17-9. doi: 10.1128/AAC.26.1.17.
6
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.在对人类志愿者进行为期7天的环丙沙星给药过程中环丙沙星的药代动力学及粪便菌群的变化。
Antimicrob Agents Chemother. 1984 Nov;26(5):757-61. doi: 10.1128/AAC.26.5.757.
7
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.致病性弧菌属对诺氟沙星及其他六种抗菌剂的体外敏感性
Antimicrob Agents Chemother. 1985 Sep;28(3):442-5. doi: 10.1128/AAC.28.3.442.
8
Pharmacokinetics: metabolism and renal excretion of quinolones in man.药代动力学:喹诺酮类药物在人体内的代谢及经肾排泄情况
Pharm Weekbl Sci. 1986 Feb 21;8(1):29-34. doi: 10.1007/BF01975476.
9
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.诺氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Dec;30(6):482-513. doi: 10.2165/00003495-198530060-00003.
10
Norfloxacin penetration into human renal and prostatic tissues.诺氟沙星在人体肾脏和前列腺组织中的渗透情况。
Antimicrob Agents Chemother. 1985 Aug;28(2):349-50. doi: 10.1128/AAC.28.2.349.